Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q44944> ?p ?o }
Showing triples 1 to 57 of
57
with 100 triples per page.
- Q44944 subject Q7145095.
- Q44944 subject Q7240335.
- Q44944 subject Q8546974.
- Q44944 subject Q8642323.
- Q44944 subject Q8732563.
- Q44944 subject Q8965786.
- Q44944 abstract "Tegaserod is a 5-HT4 agonist manufactured by Novartis and sold under the names Zelnorm and Zelmac for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects. Before then, it was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating, and constipation associated with irritable bowel syndrome. Its use was also approved to treat chronic idiopathic constipation.".
- Q44944 atcPrefix "A06".
- Q44944 atcSuffix "AX06".
- Q44944 bioavailability "10.0".
- Q44944 casNumber "189188-57-6".
- Q44944 drugbank "DB01079".
- Q44944 fdaUniiCode "458VC51857".
- Q44944 iupacName "(2E)-2-[(5-Methoxy-1H-indol-3-yl)methylene]-N-pentylhydrazinecarboximidamide".
- Q44944 pubchem "5362436".
- Q44944 thumbnail Tegaserod_structure.svg?width=300.
- Q44944 wikiPageWikiLink Q1029907.
- Q44944 wikiPageWikiLink Q1057591.
- Q44944 wikiPageWikiLink Q167934.
- Q44944 wikiPageWikiLink Q178436.
- Q44944 wikiPageWikiLink Q18027434.
- Q44944 wikiPageWikiLink Q204711.
- Q44944 wikiPageWikiLink Q30.
- Q44944 wikiPageWikiLink Q308695.
- Q44944 wikiPageWikiLink Q33596.
- Q44944 wikiPageWikiLink Q389934.
- Q44944 wikiPageWikiLink Q4927059.
- Q44944 wikiPageWikiLink Q507154.
- Q44944 wikiPageWikiLink Q586582.
- Q44944 wikiPageWikiLink Q594841.
- Q44944 wikiPageWikiLink Q6151460.
- Q44944 wikiPageWikiLink Q7145095.
- Q44944 wikiPageWikiLink Q7240335.
- Q44944 wikiPageWikiLink Q838966.
- Q44944 wikiPageWikiLink Q8546974.
- Q44944 wikiPageWikiLink Q8642323.
- Q44944 wikiPageWikiLink Q8732563.
- Q44944 wikiPageWikiLink Q8965786.
- Q44944 wikiPageWikiLink Q9368.
- Q44944 wikiPageWikiLink Q9377.
- Q44944 wikiPageWikiLink Q9597.
- Q44944 atcPrefix "A06".
- Q44944 atcSuffix "AX06".
- Q44944 bioavailability "10.0".
- Q44944 casNumber "189188".
- Q44944 drugbank "DB01079".
- Q44944 iupacName "-2".
- Q44944 pubchem "5362436".
- Q44944 unii "458".
- Q44944 type ChemicalSubstance.
- Q44944 type Drug.
- Q44944 type ChemicalObject.
- Q44944 type Thing.
- Q44944 type Q8386.
- Q44944 comment "Tegaserod is a 5-HT4 agonist manufactured by Novartis and sold under the names Zelnorm and Zelmac for the management of irritable bowel syndrome and constipation. Approved by the FDA in 2002, it was subsequently removed from the market in 2007 due to FDA concerns about possible adverse cardiovascular effects.".
- Q44944 label "Tegaserod".
- Q44944 depiction Tegaserod_structure.svg.
